UK To Keep Special Cancer Drug Fund As Battle Over NICE Rages

esilverman The pharmaceutical industry has won a victory in the UK, where the government has decided to renew more than $ 300 million in special funding for a controversial ...

ArQule rises on renewed hope for twice-damned tivantinib

Damian Garde ArQule watched its shares scrape the bottom last fall when it pulled the plug on a late-stage lung cancer drug, but rumors that the Woburn, MA, company is primed to release ...

FTC tells Mylan to sell 11 drugs to complete $1.6B Agila deal

Eric Palmer India also has signed off on Mylan's deal to buy the injectable unit from Strides Arcolab. The company reportedly agreed there to maintain the production of certain ...

Grassley Probes Two Drugmakers Over 340B Pricing Program

esilverman written two drugmakers and demanded they explain why they refused to provide required discounts to an Iowa hospital. The Iowa Republican took this move after confirming ...

Regado cuts workforce by 15% after IPO fizzle

Damian Garde A month after limping onto the biotech IPO scene with a slashed-price $ 47 million raise, Regado Biosciences is trimming about 15% of its staff, saving cash it'll ...

U.K. to extend cancer drug fund for treatments NICE rejects

Eric Palmer The cancer drug fund has been an important safety valve for some drugmakers. FiercePharma News

J&J warns doctors Doxil shortage will hit next month

Eric Palmer Johnson & Johnson's ($ JNJ) Janssen unit, which has jumped through hoops to keep supplies of ovarian cancer drug Doxil in doctors' hands, is again being hamstrung ...

One in Three Hospitalized Patients is Malnourished; Experts Call for Better Diagnosis and Treatment

barbara.lempert Underperformed Nutrition Assessment Associated with Poorer Outcomes and Higher Cost SILVER SPRING, Md., Sept. 24, 2013 /PRNewswire/ — Multiple studies find that ...

UPDATED: Yale biotech spinout launches with $18M and a new approach to cancer

John Carroll Canaan Partners and 5AM Ventures are launching a new Yale spinout focused on a new approach to shutting down proteins. FierceBiotech News

If reps can’t get in doctors’ front doors, try alternate routes

Tracy Staton According to a new study from CMI/Compas, fully half of physicians restrict visits from reps in one way or another. And the doctors reps want to see most–including ...

Ockham Source Publishes ‘Buying Guide’ for the Functional Service Provider Solution

barbara.lempert Key success factors highlighted in white paper distributed to sourcing industry CARY, NC — The president of Ockham Source, one of the leading resourcingcompanies ...

Belén Garijo named Merck Serono CEO

Alok Saboo FierceBiotech News
Page 4 of 24« First...23456...1020...Last »
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS